Topoisomerase II SUMOylation activates a metaphase checkpoint via Haspin and Aurora B kinases

J Cell Biol. 2020 Jan 6;219(1):e201807189. doi: 10.1083/jcb.201807189.

Abstract

Topoisomerase II (Topo II) is essential for mitosis since it resolves sister chromatid catenations. Topo II dysfunction promotes aneuploidy and drives cancer. To protect from aneuploidy, cells possess mechanisms to delay anaphase onset when Topo II is perturbed, providing additional time for decatenation. Molecular insight into this checkpoint is lacking. Here we present evidence that catalytic inhibition of Topo II, which activates the checkpoint, leads to SUMOylation of the Topo II C-terminal domain (CTD). This modification triggers mobilization of Aurora B kinase from inner centromeres to kinetochore proximal centromeres and the core of chromosome arms. Aurora B recruitment accompanies histone H3 threonine-3 phosphorylation and requires Haspin kinase. Strikingly, activation of the checkpoint depends both on Haspin and Aurora B. Moreover, mutation of the conserved CTD SUMOylation sites perturbs Aurora B recruitment and checkpoint activation. The data indicate that SUMOylated Topo II recruits Aurora B to ectopic sites, constituting the molecular trigger of the metaphase checkpoint when Topo II is catalytically inhibited.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aurora Kinase B / genetics
  • Aurora Kinase B / metabolism*
  • Chromosome Segregation
  • Chromosomes, Human / genetics*
  • DNA Topoisomerases, Type II / chemistry
  • DNA Topoisomerases, Type II / genetics
  • DNA Topoisomerases, Type II / metabolism*
  • Diketopiperazines
  • HeLa Cells
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Kinetochores
  • Metaphase*
  • Mitosis*
  • Phosphorylation
  • Piperazines / pharmacology
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Sumoylation*
  • Topoisomerase II Inhibitors / pharmacology

Substances

  • Diketopiperazines
  • Intracellular Signaling Peptides and Proteins
  • Piperazines
  • Topoisomerase II Inhibitors
  • 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione
  • AURKB protein, human
  • Aurora Kinase B
  • HASPIN protein, human
  • Protein Serine-Threonine Kinases
  • DNA Topoisomerases, Type II